Bay Colony Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,188
| Closed | -$212K | – | 371 |
|
|
2023
Q2 | $212K | Sell |
5,188
-712
| -12% | -$29K | 0.05% | 310 |
|
|
2023
Q1 | $213K | Sell |
5,900
-100
| -2% | -$3.6K | 0.06% | 294 |
|
|
2022
Q4 | $209K | Hold |
6,000
| – | – | 0.06% | 322 |
|
|
2022
Q3 | $336K | Buy |
6,000
+350
| +6% | +$19.6K | 0.1% | 199 |
|
|
2022
Q2 | $366K | Buy |
5,650
+450
| +9% | +$29.2K | 0.09% | 207 |
|
|
2022
Q1 | $378K | Buy |
5,200
+250
| +5% | +$18.2K | 0.09% | 221 |
|
|
2021
Q4 | $585K | Buy |
4,950
+400
| +9% | +$47.3K | 0.17% | 151 |
|
|
2021
Q3 | $610K | Hold |
4,550
| – | – | 0.2% | 140 |
|
|
2021
Q2 | $737K | Hold |
4,550
| – | – | 0.25% | 119 |
|
|
2021
Q1 | $365K | Hold |
4,550
| – | – | 0.14% | 190 |
|
|
2020
Q4 | $248K | Buy |
+4,550
| New | +$248K | 0.13% | 225 |
|